Back to Journals » Vascular Health and Risk Management » Volume 10

Cardiac angiosarcoma: utility of [18F]fluorodeoxyglucose positron emission tomography–computed tomography in evaluation of residue, metastases, and treatment response

Authors Tokmak H, Demir N, Demirkol MO

Received 18 March 2014

Accepted for publication 14 April 2014

Published 27 June 2014 Volume 2014:10 Pages 399—401


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Handan Tokmak,1 Nurhan Demir,2 Mehmet Onur Demirkol3

Department of Nuclear Medicine and Molecular Imaging, American Hospital, Nisantasi, Istanbul, 2Internal Medicine Department, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, 3Department of Nuclear Medicine and Molecular Imaging, Koç University, Istanbul, Turkey

Abstract: Cardiac angiosarcomas are a rare form of malignancy. The majority of cases arise from the right atrium as mural masses. These tumors have extremely aggressive behavior, with early clinical symptoms that vary depending on location, size, and extent of the tumor. Most of these patients have a very short survival time. Surgical therapy is considered the best choice of therapy approach in cardiac angiosarcoma patients with nonmetastatic disease, even though the disease is rarely cured. Advanced diagnostic techniques facilitate accurate, noninvasive assessments of cardiac sarcomas. We report a case of a 62-year-old man with cardiac angiosarcoma who had multiple distant metastases that were revealed by [18F]fluorodeoxyglucose positron emission tomography–computed tomography imaging.

Keywords: primary cardiac angiosarcoma, FDG PET/CT imaging, noninvasive assessment of cardiac sarcomas

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]